참고문헌
- Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group? Asian Pac J Cancer Prev, 15, 195-8. https://doi.org/10.7314/APJCP.2014.15.1.195
- Avci CB, Harman E, Dodurga Y, Susluer SY, Gunduz C (2013). Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev, 14, 765-8. https://doi.org/10.7314/APJCP.2013.14.2.765
- Chao A, Lin CY, Tsai CL, et al (2013). Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23). J Mol Med (Berl), 91, 249-59. https://doi.org/10.1007/s00109-012-0950-8
- Campagnoli C, Abba C, Ambroggio Set al (2013). Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. Gynecol Endocrinol, 29, 119-24. https://doi.org/10.3109/09513590.2012.706671
- Eftekhar Z, Izadi-Mood N, Yarandi F, et al (2009). Efficacy of megestrol acetate (Megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients. Int J Gynecol Cancer, 19, 249-52. https://doi.org/10.1111/IGC.0b013e31819c5372
- Fryer LG, Parbu-Patel A, Carling D (2002). The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem, 277, 25226-32. https://doi.org/10.1074/jbc.M202489200
- Huang X, Wellschleger S, Shapiro N, et al (2008). Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J, 412, 211-21. https://doi.org/10.1042/BJ20080557
- Hardie DG (2003). The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology, 144, 5179-83. https://doi.org/10.1210/en.2003-0982
- Jarboe EA, Mutter GL (2010). Endometrial intraepithelial neoplasia. Semin Diagn Pathol, 27, 215-25. https://doi.org/10.1053/j.semdp.2010.09.007
- Ko EM, Walter P, Jackson A, et al (2014). Metformin is associated with improved survival in endometrial cancer. Gynecol Oncol, 132, 438-42 https://doi.org/10.1016/j.ygyno.2013.11.021
- Libby G, Donnelly LA, Donnan PT, et al (2009). New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care, 32, 1620-5 https://doi.org/10.2337/dc08-2175
- Mutter GL, Zaino RJ, Baak JP, et al (2007). Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol, 26, 103-14. https://doi.org/10.1097/PGP.0b013e31802e4696
- Mutter GL (2000). Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos? Gynecol Oncol,76, 287-290. https://doi.org/10.1006/gyno.1999.5580
- Mutter GL, Baak JPA, Crum CP, et al (2002). Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol, 190, 462-9.
- Nevadunsky NS, Van Arsdale A, Strickler HD, et al (2013). Metformin use and endometrial non endometriod cancer survival. Gynecol Oncol, 132, 236-40
- Navaratnarajah R, Pillay OC, Hardiman P (2008). Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med, 26, 62-71. https://doi.org/10.1055/s-2007-992926
- Prat J, Bentley RC, Russel P, Anderson MC (2009). Endometrial intraepithelial neoplasia. In 'Robboy's Pathology of Female Reproductive Tract', Eds. Elsevier, China, pp 367-397.
- Perino A, Quartararo P, Catinella E, et al (1987). Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices. Acta Eur Fertil, 18, 137-40.
- Randall TC, Kurman RJ (1997). Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol, 90, 434-40 https://doi.org/10.1016/S0029-7844(97)00297-4
- Sarfstein R, Friedman Y, Attias-Geva Z, et al (2013). Metformin down regulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. PLoS One, 19, 61537.
- Shen ZQ, Zhu HT, Lin JF. (2008). Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Obstet Gynecol, 112, 465-7. https://doi.org/10.1097/AOG.0b013e3181719b92
- Shafiee MN, Khan G, Ariffin R, et al (2013). Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help? Gynecol Oncol, 13, 1277-8
- Thigpen JT, Brady MF, Alvarez RD, et al (1999). Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol, 17, 1736-44.
- Tas M, Kutuk MS, Serin IS, et al (2013). Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats. Gynecol Endocrinol, 29, 311-4. https://doi.org/10.3109/09513590.2012.743010
- van Meurs HS, Bleeker MC, van der Velden J, et al (2013). The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study. Int J Gynecol Cancer, 23, 1417-22. https://doi.org/10.1097/IGC.0b013e3182a57fb4
- Wheeler DT, Bristow RE, Kurman RJ (2007). Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol, 31, 988-98. https://doi.org/10.1097/PAS.0b013e31802d68ce
- Zhou G, Myers R, Li Y, et al (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest, 108, 1167-74 https://doi.org/10.1172/JCI13505
- Zakikhani M, Dowling R, Fantus IG, et al (2006). Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res, 66, 10267-73.
피인용 문헌
- The Impact of Diabetes on Gynecologic Cancer: Current Status and Future Directions vol.4, pp.4, 2015, https://doi.org/10.1007/s13669-015-0127-x
- The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development vol.11, pp.4, 2016, https://doi.org/10.1007/s11523-016-0423-z
- A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia vol.33, pp.2, 2017, https://doi.org/10.1080/09513590.2016.1223285
- Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management vol.5, pp.3, 2017, https://doi.org/10.3390/healthcare5030030
- Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6 vol.8, pp.4, 2017, https://doi.org/10.1007/s12672-017-0295-4
- Induction of apoptosis by metformin and progesterone in estrogen-induced endometrial hyperplasia in rats: involvement of the bcl-2 family proteins pp.1473-0766, 2017, https://doi.org/10.1080/09513590.2017.1409708
- Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment vol.12, pp.5, 2016, https://doi.org/10.3892/ol.2016.5041
- Metformin as a Therapeutic Target in Endometrial Cancers vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00341